(melle-4)cyclosporin

1.	Springer, Joe E: 2 articles (10/2007 - 04/2007)
2.	McEwen, Melanie L: 2 articles (10/2007 - 04/2007)
3.	Sullivan, P G: 1 article (01/2008)
4.	Theruvath, Tom P: 1 article (01/2008)
5.	Ramshesh, Venkat K: 1 article (01/2008)
6.	Singh, I N: 1 article (01/2008)
7.	Tikunov, Andrey: 1 article (01/2008)
8.	Springer, J E: 1 article (01/2008)
9.	Holmuhamedov, Ekhson: 1 article (01/2008)
10.	Mbye, L H: 1 article (01/2008)

Related Diseases

1.	Brain Ischemia (Cerebral Ischemia) 05/01/2007 - "Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition." 05/01/2007 - "The results of these studies demonstrate that NIM811 provides almost 40% protection in a model of transient focal cerebral ischemia" Get all the results and reference details, order at left...
2.	Spinal Cord Injuries (Spinal Cord Injury) 04/01/2007 - "Rats were pretreated with NIM811 or vehicle, and after 15 min the rats received a "mild/moderate" spinal cord contusion" 04/01/2007 - "In the present study, we investigated the effects of NIM811 treatment on mitochondrial bioenergetics and the production of reactive oxygen species following spinal cord injury (SCI) in rats" 10/01/2007 - "Post-treatment with the cyclosporin derivative, NIM811, reduced indices of cell death and increased the volume of spared tissue in the acute period following spinal cord contusion." 04/01/2007 - "Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats." Get all the results and reference details, order at left...
3.	Neoplasms (Cancer) 10/20/2005 - "Studies in murine model of melanoma showed that NIM811, but not CsA, retards tumor progression and significantly decreases tumor volume after intratumoral application" Get all the results and reference details, order at left...
4.	Myocardial Infarction 02/01/2005 - "The aim of the present study was to determine whether specific inhibition of mitochondrial permeability transition (MPT) by NIM811 at the time of reperfusion following acute myocardial infarction may protect the heart" Get all the results and reference details, order at left...
5.	Melanoma (Melanoma, Malignant) 10/20/2005 - "In our present study, we investigated effects of CsA and its nonimmunosuppressive derivative NIM811 on survival of human and murine melanoma cells" 10/20/2005 - "CsA and NIM811 induced a significant increase in subG1 population of murine B16F10 melanoma cells indicative of apoptotic DNA fragmentation" 10/20/2005 - "We demonstrated that CsA and NIM811 affect survival of human and murine melanoma cells and induce morphological changes, alterations in nuclear morphology and an internucleosomal DNA fragmentation, consistent with an apoptotic type of death" 10/20/2005 - "Studies in murine model of melanoma showed that NIM811, but not CsA, retards tumor progression and significantly decreases tumor volume after intratumoral application" 10/20/2005 - "Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies." Get all the results and reference details, order at left...
13 Diseases and 12 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cyclosporine (Ciclosporin)
2.	Reactive Oxygen Species (Oxygen Radicals)
3.	Cyclophilins (Cyclophilin)
4.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
5.	Minocycline (Cyclops)
6.	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
7.	Atractyloside
7 Drugs and Important Bio-Agents and 8 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Liver Transplantation
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>